✦ LIBER ✦

Azacitidine salvage therapy for relapse of myeloid malignancies following allogeneic hematopoietic SCT

✍ Scribed by Tessoulin, B; Delaunay, J; Chevallier, P; Loirat, M; Ayari, S; Peterlin, P; Le Gouill, S; Gastinne, T; Moreau, P; Mohty, M; Guillaume, T

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monitoring and Prevention of Relapse aft

✍ Ulrike Bacher; Julie-An Talano; Michael R. Bishop 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 729 KB

Feasibility of Low Dose Azacitidine Post

✍ Tamari, Roni; Ponce, Doris; Jakubowski, Ann A.; Giralt, Sergio A.; Young, James; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Impact on relapse of corticosteroid ther

✍ Nobuhiko Imahashi; Yoshihiro Inamoto; Aika Seto; Keisuke Watanabe; Satoshi Nishi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Azacitidine and donor lymphocyte infusio

✍ Schroeder, T; Czibere, A; Platzbecker, U; Bug, G; Uharek, L; Luft, T; Giagounidi 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 435 KB

Combining Azacitidine (Vidaza®, Aza) and

✍ T. Schroeder; A.G. Czibere; N. Kröger; U. Platzbecker; G. Bug; L. Uharek; T. Luf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

NCI First International Workshop on the

✍ Edwin P. Alyea; Daniel J. DeAngelo; Jeffrey Moldrem; John M. Pagel; Donna Przepi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 564 KB